FTDI
First Trust Direct Indexing’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,868
| Closed | -$2.73M | – | 906 |
|
|
2024
Q3 | $2.73M | Buy |
5,868
+335
| +6% | +$156K | 0.15% | 132 |
|
|
2024
Q2 | $2.59M | Buy |
5,533
+1,415
| +34% | +$663K | 0.16% | 115 |
|
|
2024
Q1 | $1.72M | Buy |
4,118
+666
| +19% | +$278K | 0.13% | 166 |
|
|
2023
Q4 | $1.4M | Buy |
3,452
+1,186
| +52% | +$483K | 0.13% | 182 |
|
|
2023
Q3 | $788K | Buy |
2,266
+216
| +11% | +$75.1K | 0.09% | 271 |
|
|
2023
Q2 | $721K | Buy |
2,050
+263
| +15% | +$92.6K | 0.08% | 300 |
|
|
2023
Q1 | $563K | Buy |
1,787
+91
| +5% | +$28.7K | 0.07% | 366 |
|
|
2022
Q4 | $490K | Buy |
1,696
+1
| +0.1% | +$289 | 0.07% | 387 |
|
|
2022
Q3 | $491K | Buy |
1,695
+167
| +11% | +$48.4K | 0.07% | 344 |
|
|
2022
Q2 | $431K | Buy |
1,528
+106
| +7% | +$29.9K | 0.06% | 380 |
|
|
2022
Q1 | $371K | Buy |
1,422
+145
| +11% | +$37.8K | 0.05% | 443 |
|
|
2021
Q4 | $280K | Buy |
1,277
+44
| +4% | +$9.65K | 0.04% | 507 |
|
|
2021
Q3 | $224K | Sell |
1,233
-312
| -20% | -$56.7K | 0.03% | 560 |
|
|
2021
Q2 | $312K | Sell |
1,545
-942
| -38% | -$190K | 0.05% | 453 |
|
|
2021
Q1 | $534K | Sell |
2,487
-1,443
| -37% | -$310K | 0.14% | 196 |
|
|
2020
Q4 | $929K | Buy |
+3,930
| New | +$929K | 0.25% | 90 |
|